Dr John Buscombe
British Nuclear Medicine Society
Dr John Buscombe is the President of the British Nuclear Medicine Society and works as a Consultant Physician in Nuclear Medicine in Cambridge.
Theranostics in prostate cancer new or false dawn
Over the past 2 years new imaging and therapeutic options using radiolabelled prostate specific membrane antigen have been developed which enable us to see disease which cannot be found by other methods with gallium-68 PSMA PET-CT. Newer work has linked this to targeted radionuclide therapy using beta and alpha emitter labelled PSMA is previously untreatable metastatic prostate cancer which is being actively developed.
EVEN MORE SEMINARS
Professor Patricia Price Action Radio Therapy
Action Radiotherapy -a charity for radiotherapy patients and professionals.
Andy Rogers Nottingham University Hospitals
Interventional staff dose reduction: Gaining insight through new technology
Dr Sujal Desai The Royal Brompton & Harefield NHS Foundation Trust
An approach to diffuse lung disease: Learn from the experts
Dr Sam Hare Royal Free London NHS Foundation Trust
How I evaluate lung lesions for CT-guided biopsy?
Sabine Sartoretti Institut für Radiologie, Kantonsspital Winterthur, Brauerstrasse 15, 8401 Winterthur
Compressed Sense Technique in Neuroradiology